117 related articles for article (PubMed ID: 38452705)
1. Generation of an induced pluripotent stem cell line GWCMCi006-A from a patient with autosomal dominant neurodevelopmental disorder with or without hyperkinetic movements and seizures harboring GRIN1 c.389A > G mutation.
Shi Z; Liu H; Feng F; Huang Z; Chen WX
Stem Cell Res; 2024 Apr; 76():103371. PubMed ID: 38452705
[TBL] [Abstract][Full Text] [Related]
2. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
3. Generation of an induced pluripotent stem cell line ZZUNEUi019-A from a five-year-old Chinese girl with Susceptibility to idiopathic generalized epilepsy-15.
Dong W; Shi D; Zhang L; Huang M; Luo Q
Stem Cell Res; 2021 Mar; 51():102177. PubMed ID: 33540281
[TBL] [Abstract][Full Text] [Related]
4. Generation of an induced pluripotent stem cell line (GWCMCi005-A) from a patient with Lennox-Gastaut syndrome carrying TANC2 Gln1441Ter mutation.
Tian Y; Shi Z; Liao Y; Cai J; Li W; Li X; Chen WX
Stem Cell Res; 2022 Apr; 60():102667. PubMed ID: 35066241
[TBL] [Abstract][Full Text] [Related]
5. Generation of an induced pluripotent stem cell line ATCi002-A from a two-year-old chinese boy with Keipert syndrome.
Lu X; Mai J; Liu L; Chen X; Shen Y
Stem Cell Res; 2022 Apr; 60():102706. PubMed ID: 35168097
[TBL] [Abstract][Full Text] [Related]
6. Generation of induced pluripotent stem cell line (RCMGi009-A) from urine cells of patient with fibrodysplasia ossificans progressiva.
Kondrateva E; Grigorieva O; Kurshakova E; Panchuk I; Pozhitnova V; Voronina E; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2023 Aug; 70():103133. PubMed ID: 37307755
[TBL] [Abstract][Full Text] [Related]
7. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
[TBL] [Abstract][Full Text] [Related]
8. Generation of the human induced pluripotent stem cell line PUMCi005-A from a patient with Perrault syndrome.
Wang YB; Lv YF; Zhang Y; Wang W
Stem Cell Res; 2024 Mar; 75():103318. PubMed ID: 38295749
[TBL] [Abstract][Full Text] [Related]
9. Generation of induced pluripotent stem cell line (RCMGi012-A) from fibroblasts of patient with mucopolysaccharidosis type VI.
Kondrateva E; Grigorieva O; Panchuk I; Bychkov I; Zakharova E; Tabakov V; Pozhitnova V; Voronina E; Shchagina O; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2023 Dec; 73():103259. PubMed ID: 38006675
[TBL] [Abstract][Full Text] [Related]
10. Generation of an induced pluripotent stem cell line (SDQLCHi044-A) from a patient with autosomal dominant mental retardation type 5 harboring heterozygous mutation in SYNGAP1 gene.
Wang Y; Lv Y; Yang X; Li Y; Li Z; Gao Z; Gai Z; Liu Y
Stem Cell Res; 2022 Oct; 64():102922. PubMed ID: 36183676
[TBL] [Abstract][Full Text] [Related]
11. GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders.
Ohba C; Shiina M; Tohyama J; Haginoya K; Lerman-Sagie T; Okamoto N; Blumkin L; Lev D; Mukaida S; Nozaki F; Uematsu M; Onuma A; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Kato M; Ogata K; Saitsu H; Matsumoto N
Epilepsia; 2015 Jun; 56(6):841-8. PubMed ID: 25864721
[TBL] [Abstract][Full Text] [Related]
12. Generation of a human iPSC line (HIMRi001-A) from a patient with filaminopathy.
Daya NM; Mavrommatis L; Zhuge H; Athamneh M; Roos A; Gläser D; Doering K; Zaehres H; Vorgerd M; Güttsches AK
Stem Cell Res; 2023 Oct; 72():103210. PubMed ID: 37748332
[TBL] [Abstract][Full Text] [Related]
13. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1.
Moon SY; Zhang D; Chen SC; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Chen FK; McLenachan S
Stem Cell Res; 2021 Jul; 54():102403. PubMed ID: 34034222
[TBL] [Abstract][Full Text] [Related]
14. Derivation of an induced pluripotent stem cell line (FDCHi014-A) from PBMCs of a seven-year-old patient with a truncating NOVA2 variant (c.625del).
Yin T; Qian Y; Zhang X; Liao Y; Wu B; Wang S; Wang H
Stem Cell Res; 2024 Apr; 76():103369. PubMed ID: 38430735
[TBL] [Abstract][Full Text] [Related]
15. Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy.
Lemke JR; Geider K; Helbig KL; Heyne HO; Schütz H; Hentschel J; Courage C; Depienne C; Nava C; Heron D; Møller RS; Hjalgrim H; Lal D; Neubauer BA; Nürnberg P; Thiele H; Kurlemann G; Arnold GL; Bhambhani V; Bartholdi D; Pedurupillay CR; Misceo D; Frengen E; Strømme P; Dlugos DJ; Doherty ES; Bijlsma EK; Ruivenkamp CA; Hoffer MJ; Goldstein A; Rajan DS; Narayanan V; Ramsey K; Belnap N; Schrauwen I; Richholt R; Koeleman BP; Sá J; Mendonça C; de Kovel CG; Weckhuysen S; Hardies K; De Jonghe P; De Meirleir L; Milh M; Badens C; Lebrun M; Busa T; Francannet C; Piton A; Riesch E; Biskup S; Vogt H; Dorn T; Helbig I; Michaud JL; Laube B; Syrbe S
Neurology; 2016 Jun; 86(23):2171-8. PubMed ID: 27164704
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.
Raina K; Joshi G; Modak K; Premkumar C; Priyanka S; Rajesh P; Velayudhan SR; Thummer RP
Stem Cell Res; 2023 Sep; 71():103159. PubMed ID: 37392703
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of iPS cell line (CTGUi001-A) from skin fibroblasts of a patient with Fabry disease.
Qin Y; Zhan JQ; Ma CJ; Cao CY; Zhang Y; Min YT; Lv YF
Stem Cell Res; 2023 Jun; 69():103063. PubMed ID: 36917862
[TBL] [Abstract][Full Text] [Related]
18. Generation of an induced pluripotent stem cell line SDPHi002-A from a patient with lung cancer.
Ai D; Yang X; Li X; Liu N; Xie X; Liu Y; Song W
Stem Cell Res; 2023 Jun; 69():103096. PubMed ID: 37104933
[TBL] [Abstract][Full Text] [Related]
19. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
[TBL] [Abstract][Full Text] [Related]
20. Generation of induced pluripotent stem cell line (RCMGi008-A) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/CFTRdele2.3 mutations in CFTR gene.
Kondrateva E; Panchuk I; Demchenko A; Grigorieva O; Zheglo D; Voronina E; Erofeeva A; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2022 Aug; 63():102854. PubMed ID: 35843019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
